| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 31.355 | 31.350 | 27.485 | 27.577 | 37.978 | 30.345 | 25.467 | 25.836 | 35.118 | 26.005 |
| Total Income - EUR | 31.355 | 31.350 | 27.485 | 27.795 | 38.152 | 34.432 | 25.670 | 26.581 | 35.320 | 26.005 |
| Total Expenses - EUR | 19.742 | 36.192 | 30.069 | 29.622 | 31.307 | 29.665 | 24.597 | 27.846 | 30.081 | 22.259 |
| Gross Profit/Loss - EUR | 11.613 | -4.843 | -2.584 | -1.827 | 6.845 | 4.767 | 1.073 | -1.265 | 5.239 | 3.746 |
| Net Profit/Loss - EUR | 10.672 | -5.237 | -2.859 | -2.103 | 6.465 | 4.463 | 818 | -1.523 | 4.887 | 2.961 |
| Employees | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Medisol Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.436 | 658 | 21 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 47.636 | 42.638 | 39.930 | 37.510 | 38.064 | 47.307 | 45.262 | 45.840 | 49.831 | 56.684 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 30.434 | 29.632 | 28.072 | 37.303 | 37.758 | 6.456 | 15.545 | 45.451 | 49.788 | 56.569 |
| Cash | 17.202 | 13.007 | 11.858 | 207 | 306 | 40.851 | 29.717 | 389 | 42 | 116 |
| Shareholders Funds | 46.115 | 40.407 | 36.864 | 34.085 | 39.890 | 43.597 | 43.448 | 42.059 | 46.819 | 49.519 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.957 | 2.889 | 3.087 | 3.425 | 3.637 | 3.710 | 1.814 | 3.781 | 3.011 | 7.166 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Medisol Srl